Co-Diagnostics will license its CoPrimers technology to Biosearch to make, use, market, and sell the primer-dimer-reducing oligonucleotides.
The sensitivity of real-time PCR-based testing of dried blood spots is too low to use the method as a routine test for CMV infection in newborns. Despite this, PCR testing of other bodily fluids such as saliva still holds promise for such a test.
Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.
CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.
The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.
In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.